In the said notification, in the Table, against serial number 9, relating to the State of Maharashtra, in column (3) the item (iv), and the corresponding entry thereto in column (4) shall be omitted. ...

在医保基金政策的支持下，行业普遍认为，合成生物学等技术创新将为医药板块的整体复苏注入新的活力。通过缓解医疗机构的资金流动压力，这一政策将推动医药板块的持续增长和发展。随着合成生物学在药物研发等关键领域的应用前景不断扩大，医药行业或将在政策扶持和技术创新的双重驱动下迎来稳步增长。

Notification No. 24/2024-Customs (ADD) Dated: 11th November, 2024: CBIC imposes ADD on Epichlorohydrin imported from China PR, Korea RP and Thailand for 5 years, pursuant to final findings of DGTR.